Menu

Biosphere Researcher Killed in Accident

University of Arizona Professor Raphael Sagarin has died. He was struck by a truck while riding his bicycle.

Jun 2, 2015
Jef Akst

RAFESAGARIN.COMUniversity of Arizona (UA) marine ecologist Raphael “Rafe” Sagarin was killed Thursday (May 28) when a pickup truck swerved partially off the road and hit Sagarin from behind while he was on his bicycle, the Arizona Daily Star reported. He was 43.

The driver, Gary Colvin, was allegedly impaired at the time and was charged with manslaughter.

Sagarin was leading a project at UA’s Biosphere 2 to create a living model of the Gulf of California. He was also an expert in adaptability and would consult with the American Red Cross, the US Department of Defense, and large corporations “on how they can unleash the natural power of adaptability to survive and thrive in an unpredictable world,” according to his website. His books included Learning from the Octopus: How Secrets from Nature Can Help Us Fight Terrorism, Natural Disasters, and Disease and Observation and Ecology: Broadening the Scope of Science to Understand a Complex World.

“Dr. Sagarin was committed to education and research, and understood that the Biosphere was a unique platform for science and education. He represented all of us in our commitment to quality and making things better,” Joaquin Ruiz, dean of the UA College of Science, said in a statement. “Rafe will be deeply missed. His energy and enthusiasm were contagious, and it was a blessing to have known such wonderful colleague.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.